Edesa Biotech, Inc. (EDSA)

Edesa Biotech Statistics

Total Valuation

Edesa Biotech has a market cap or net worth of $12.42 million. The enterprise value is $1.04 million.

Market Cap	12.42M
Enterprise Value	1.04M

Important Dates

The next estimated earnings date is Friday, February 13, 2026, after market close.

Earnings Date	Feb 13, 2026
Ex-Dividend Date	n/a

Share Statistics

Edesa Biotech has 8.33 million shares outstanding. The number of shares has increased by 77.54% in one year.

Current Share Class	8.33M
Shares Outstanding	8.33M
Shares Change (YoY)	+77.54%
Shares Change (QoQ)	+0.46%
Owned by Insiders (%)	6.35%
Owned by Institutions (%)	2.27%
Float	5.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.18
P/TBV Ratio	9.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.67

Current Ratio	10.67
Quick Ratio	10.60
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -99.57% and return on invested capital (ROIC) is -68.42%.

Return on Equity (ROE)	-99.57%
Return on Assets (ROA)	-57.02%
Return on Invested Capital (ROIC)	-68.42%
Return on Capital Employed (ROCE)	-63.54%
Revenue Per Employee	n/a
Profits Per Employee	-$422,678
Employee Count	17
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Edesa Biotech has paid $800 in taxes.

Income Tax	800
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -10.71% in the last 52 weeks. The beta is 0.13, so Edesa Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.13
52-Week Price Change	-10.71%
50-Day Moving Average	1.76
200-Day Moving Average	2.15
Relative Strength Index (RSI)	44.00
Average Volume (20 Days)	50,205

Short Selling Information

The latest short interest is 34,823, so 0.42% of the outstanding shares have been sold short.

Short Interest	34,823
Short Previous Month	51,065
Short % of Shares Out	0.42%
Short % of Float	0.69%
Short Ratio (days to cover)	1.09

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-7.91M
Pretax Income	-7.18M
Net Income	-7.19M
EBITDA	-7.79M
EBIT	-7.91M
Earnings Per Share (EPS)	-$1.27

Balance Sheet

The company has $10.79 million in cash and n/a in debt, giving a net cash position of $10.79 million or $1.29 per share.

Cash & Cash Equivalents	10.79M
Total Debt	n/a
Net Cash	10.79M
Net Cash Per Share	$1.29
Equity (Book Value)	12.45M
Book Value Per Share	0.45
Working Capital	10.43M

Cash Flow

Operating Cash Flow	-7.32M
Capital Expenditures	n/a
Free Cash Flow	-7.32M
FCF Per Share	-$0.88

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Edesa Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-77.54%
Shareholder Yield	n/a
Earnings Yield	-60.72%
FCF Yield	-61.87%

Analyst Forecast

The average price target for Edesa Biotech is $13.00, which is 772.48% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$13.00
Price Target Difference	772.48%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on October 11, 2023. It was a reverse split with a ratio of 1:7.

Last Split Date	Oct 11, 2023
Split Type	Reverse
Split Ratio	1:7

Scores

Altman Z-Score	n/a
Piotroski F-Score	1